The FDA has approved semaglutide as a safe way to help with weight management and weight-related conditions
Nearly half a billion people currently live with diabetes and more than one billion people are living with obesity
However, the relationship between GLP-1 therapy, weight loss, and bone health remains complex and context-dependent
Be sure to follow your doctors instructions for using Ozempic
Semaglutide works by decreasing appetite, which can lead to reduced calorie intake and subsequent weight loss
In a recent study published in JAMA Psychiatry , a team of researchers from Europe investigated whether glucagon-like peptide-1 receptor (GLP-1) agonists, which are primarily used to treat diabetes and obesity, could be used to reduce alcohol use disorder (AUD)-related hospitalizations